Why IMU is a multi multi bagger, page-21416

You guys make me laugh. All I have to support my position is Big Pharma's complete lack of interest in Imugene. And when it comes to small pharma, that's all that matters.

"Its just that no one knows about Imugene". Really? An ASX 200 company that's been on national TV and in national newspapers, whose CEO has presented for two years in a row at the (apparently) most prestigious and internationally recognised investor conference and who employs a guy on $1m per year just to be constantly on the phone with Big Parma and? ..... crickets.

You're a shrill little personal attacker @Watmighthavben and you get your knickers in a knot with anyone who doesn't bow down to your self-assessed superior intellect. Why do you waste your time on HC? Shouldn't you be convincing those at BP about how stupid they are not recognising this gem? You spend more time attacking this uneducated poster than writing to them. That's the action of a superbrain is it?

Let's see if you can wrap your big head around this: the orange juice comment was an analogy. It could have been something about that person's particular physiology and reaction to Vaxinia that resulted in the remission. That's why we have clinical trials that require testing on 100s if not 1,000s of patients. Its a very possible outcome for Vaxinia to assist some but not all. And if that some is too small, it won't be commercialised.

And that's the point. 1/38 proves nothing. Even if it was Vaxinia that "cured" the patient, its not exciting enough - at least at this stage - for BP to take any interest.

And yes, @Jov88 Fast Track is a good sign, but its not a slam dunk. Go read the post of WMHB to which I replied. So much of what he writes is boilerplate fluff. Look at his rationale for his $10b to $80b valuations. Then let us know which is the garbage post.